Raj Shah to Double-Blind Method
This is a "connection" page, showing publications Raj Shah has written about Double-Blind Method.
Connection Strength
0.517
-
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease. Curr Alzheimer Res. 2014; 11(6):564-73.
Score: 0.102
-
Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) Observational Study. Contemp Clin Trials. 2023 07; 130:107231.
Score: 0.049
-
Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial. Ann Intern Med. 2022 05; 175(5):761-764.
Score: 0.045
-
Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial. Mol Psychiatry. 2021 09; 26(9):5161-5170.
Score: 0.042
-
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial. JAMA Psychiatry. 2020 10 01; 77(10):1012-1020.
Score: 0.041
-
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology. 2020 07 21; 95(3):e320-e331.
Score: 0.039
-
Circulating Dkk1 and TRAIL Are Associated With Cognitive Decline in Community-Dwelling, Older Adults With Cognitive Concerns. J Gerontol A Biol Sci Med Sci. 2018 11 10; 73(12):1688-1694.
Score: 0.036
-
Effect of Aspirin on Disability-free Survival in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1499-1508.
Score: 0.035
-
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1509-1518.
Score: 0.035
-
The aspirin in reducing events in the elderly trial: Statistical analysis plan. Int J Stroke. 2018 04; 13(3):335-338.
Score: 0.033
-
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study. J Gerontol A Biol Sci Med Sci. 2017 Oct 12; 72(11):1586-1593.
Score: 0.033
-
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):51.
Score: 0.028